Molecular Modeling and Drug Design
  • About us
  • Research
  • Publications
  • Members
  • Webservers
  • Calendar
  • Blog
  • Benchmarks
  • ALLODD
  • Image Gallery
  • Publicity
  • Talks
Picture
You want to participate in a training programme in and beyond the fields of physical chemistry of biological systems, theoretical and computational chemistry, biological chemistry, biochemistry, targeted drug delivery/discovery and medicinal chemistry?

14 Early Stage Researcher (ESR) positions are available within the EU-funded Marie Skłodowska Curie Innovative Training Network on Allostery in Drug Discovery (ALLODD).

The ALLODD project is a collaboration between 13 academic and industrial organizations with 14 ESR/PhD students in total. The aim of ALLODD is to train a new generation of scientists to exploit the concept of allostery in drug design, putting together a whole array of technologies to identify and characterize allosteric modulators of protein function that will be applied to therapeutically relevant systems.


Picture
We provide a structured 3-year cutting-edge Research/PhD training programme in and beyond the fields of physical chemistry of biological systems, theoretical and computational chemistry, biological chemistry, biochemistry, targeted drug delivery/discovery and medicinal chemistry,  in the following highly reputed organisations:


  1. BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS  (BRFAA), Cournia Lab Greece
  2. UNIVERSITY OF VIENNA (UNIVIE), Rademacher Lab, Austria
  3. UNIVERSITAT DE BARCELONA (UB), Barril Lab, Spain
  4. UNIVERSITAT DE BARCELONA (UB), Curutchet Lab, Spain
  5.  FORSCHUNGSZENTRUM JULICH GMBH (FZJ), Rossetti Lab, Germany 
  6. CHARITE – UNIVERSITAETSMEDIZIN BERLIN (Charité), Scheerer Lab, Germany
  7. TERMESZETTUDOMANYI KUTATOKOZPONT/Research Center for Natural Sciences (RCNS), Keserű Lab, Hungary
  8. LEIBNIZ-RESEARCH INSTITUTE FOR MOLECULAR PHARMACOLOGY (FMP) in FORSCHUNGSVERBUND BERLIN EV (FVB), Nazaré Lab, Germany
  9. KAROLINSKA INSTITUTET (KI), Zubarev Lab, Sweden
  10. HEPTARES THERAPEUTICS LIMITED (Heptares), United Kingdom
  11. UNIVERSITE DE STRASBOURG (Unistra), Cecchini Lab, France
  12. MERCK HEALTHCARE KGAA (Merck), Germany
  13. JANSSEN PHARMACEUTICA NV (Janssen), Belgium
  14. UNIVERSITY OF URBINO (UNIURB),Bottegoni Lab, Italy

The earliest starting date will be 1 November 2021. The latest will be 1 September 2022.

We are looking for highly motivated and talented researchers at the beginning of their carrier that are interested in the aforementioned scientific fields based on the specific requirements noted below for each position. Excellent command of spoken and written English, communication skills as well as team spirit are essential.

We are offering a competitive, interdisciplinary environment with a track record of intense mutual collaboration. In addition to the individual training-through-research, our programme includes further elements such as workshops, summer schools, internships and secondments to the partners’ laboratories.

The following eligibility rules apply for participation in a Marie Skłodowska Curie Innovative Training Network:
Applicants must be in the first 4 years after obtaining their Master's degree and/or Bachelor’s degree and must not have resided or carried out their main activity (work, studies, etc.) in the host country for more than 12 months in the 3 years immediately before the recruitment date. In addition, local regulations of the host countries may apply. The salary is based on standard living, mobility and family allowances which are adapted to the respective country of recruitment.

Find below all the available ESR/PhD positions.
Picture
"Development of a computational methodology to detect allosteric pathways in proteins and application in drug discovery"

Scientist-in-Charge: Dr. Zoe Cournia


Picture
"Allosteric modulators of Fbw7 E3 ligase"

Scientist-in-Charge: Prof. Xavier Barril (www.ub.edu/bl)


Picture
"Allosteric drugs development for receptor mosaics"

Scientist-in-Charge: Prof. Giulia Rossetti


Picture
"Design and synthesis of covalent allosteric probes"

Scientist-in-Charge: Dr. György Keserű


Picture
"Identification of target binding sites using HDX MS and off-targets using Proteome Thermo Profiling"

Scientist-in-Charge:
 Dr. Roman Zubarev


Picture
"Rational design of positive and negative allosteric modulators of pLGICs"

Scientist-in-Charge: 
Prof. Marco Cecchini


Picture
"Validation and prospective application of allosteric binding site detection and ligand identification"

Scientist-in-Charge:
 Dr. Herman van Vlijmen


Picture
"Biophysical characterization of allosteric interactions using NMR spectroscopy"

Scientist-in-Charge: Dr. Christoph Rademacher


Picture
"Excitation energy transfer applied to drug design"

Scientist-in-Charge: Prof. Carles Curutchet


Picture
"Structural elucidation of allosteric mechanisms in G-protein coupled receptors or other membrane proteins by structural biology methods"

Scientist-in-Charge: Dr. Patrick Scheerer


Picture
"Design and synthesis of allosteric phosphatase inhibitors"

Scientist-in-Charge:
 Dr. Marc Nazaré


Picture
"Computer-aided drug discovery of GPCR allosteric modulators"

Scientist-in-Charge: Dr. Chris de Graaf


Picture
"Identification of new targets from screening using biochemical and cell based assays"

Scientist-in-Charge:
 Dr. Lars Toleikis


Picture
"Allosteric modulation of GPCRs at the protein – membrane interface"

Scientist-in-Charge:
 Prof. Giovanni Bottegoni


Powered by Create your own unique website with customizable templates.